Venture Visionary Partners LLC lessened its position in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 15.4% during the 1st quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 15,329 shares of the healthcare conglomerate's stock after selling 2,794 shares during the period. Venture Visionary Partners LLC's holdings in UnitedHealth Group were worth $8,029,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also recently made changes to their positions in UNH. Citizens National Bank Trust Department lifted its position in UnitedHealth Group by 1.0% during the first quarter. Citizens National Bank Trust Department now owns 17,886 shares of the healthcare conglomerate's stock valued at $9,368,000 after purchasing an additional 170 shares during the period. Fort Washington Investment Advisors Inc. OH lifted its position in UnitedHealth Group by 0.3% during the first quarter. Fort Washington Investment Advisors Inc. OH now owns 530,103 shares of the healthcare conglomerate's stock valued at $277,641,000 after purchasing an additional 1,465 shares during the period. Sherbrooke Park Advisers LLC bought a new position in UnitedHealth Group during the fourth quarter valued at approximately $515,000. Full Sail Capital LLC lifted its position in UnitedHealth Group by 2.1% during the fourth quarter. Full Sail Capital LLC now owns 1,612 shares of the healthcare conglomerate's stock valued at $815,000 after purchasing an additional 33 shares during the period. Finally, Soros Fund Management LLC bought a new position in UnitedHealth Group in the fourth quarter worth approximately $39,413,000. Institutional investors own 87.86% of the company's stock.
Insider Activity
In related news, CEO Patrick Hugh Conway sold 589 shares of UnitedHealth Group stock in a transaction dated Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the completion of the sale, the chief executive officer owned 10,398 shares in the company, valued at $3,171,390. This trade represents a 5.36% decrease in their position. The sale was disclosed in a filing with the SEC, which is available through the SEC website. Company insiders own 0.28% of the company's stock.
Wall Street Analyst Weigh In
UNH has been the topic of several recent research reports. UBS Group reiterated a "buy" rating on shares of UnitedHealth Group in a research report on Thursday, July 17th. Baird R W downgraded shares of UnitedHealth Group from a "hold" rating to a "strong sell" rating in a research report on Thursday, July 31st. Piper Sandler reduced their price objective on shares of UnitedHealth Group from $353.00 to $317.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Raymond James Financial cut shares of UnitedHealth Group from a "strong-buy" rating to a "market perform" rating in a research note on Wednesday, May 14th. Finally, Deutsche Bank Aktiengesellschaft reduced their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating for the company in a research note on Wednesday, May 14th. Three research analysts have rated the stock with a sell rating, seven have given a hold rating and fifteen have assigned a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Hold" and an average target price of $367.71.
Check Out Our Latest Report on UNH
UnitedHealth Group Stock Performance
Shares of NYSE:UNH opened at $308.84 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The stock has a market capitalization of $279.71 billion, a P/E ratio of 13.38, a PEG ratio of 1.96 and a beta of 0.43. The firm has a fifty day simple moving average of $289.03 and a two-hundred day simple moving average of $394.17. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. UnitedHealth Group's revenue was up 12.9% compared to the same quarter last year. During the same quarter last year, the business posted $6.80 EPS. On average, analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th will be issued a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.9%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is 38.30%.
UnitedHealth Group Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Further Reading
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.